Kilitch Drugs

{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "188.60",
    "chg": 21.4,
    "chgp": "12.8%",
    "dir": 1,
    "prev_price": "167.20",
    "mcapval": "599.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE729D01010",
    "curr_date": "Jun 09, 03:30 PM",
    "curr_time": "06:26 AM",
    "last_traded_at": "Jun 09, 03:30 PM IST",
    "bse_nse_vol": "3.49 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 09, 2026",
    "traded_date_str": "2026 06 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kilitch Drugs Upgraded to Hold as Technicals Improve Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-upgraded-to-hold-as-technicals-improve-amid-mixed-financial-signals-4040132",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_mojoScore_4040132.png",
        "date": "2026-06-09 08:02:09",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent price volatility and a challenging one-year return, the company’s underlying fundamentals and technical signals have prompted a reassessment of its market stance."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-4036727",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_technicaldot_4036727.png",
        "date": "2026-06-08 08:00:20",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite mixed signals from key technical indicators such as MACD, RSI, and moving averages, the stock’s recent price action and broader market context suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Faces Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-faces-mixed-technical-signals-amid-price-momentum-shift-4035120",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_technicaldot_4035120.png",
        "date": "2026-06-04 08:00:37",
        "description": "Kilitch Drugs (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, monthly signals suggest caution, reflected in the company’s downgrade from Hold to Sell by MarketsMOJO on 1 June 2026."
      },
      {
        "title": "Kilitch Drugs (India) Ltd: Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-signals-4032699",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_technicaldot_4032699.png",
        "date": "2026-06-03 08:00:29",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bearish trend to a sideways pattern. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock exhibits a complex interplay of technical indicators, reflecting both bullish and bearish signals across different timeframes."
      },
      {
        "title": "Kilitch Drugs Downgraded to Sell Amid Mixed Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-downgraded-to-sell-amid-mixed-financials-and-bearish-technicals-4029259",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_mojoScore_4029259.png",
        "date": "2026-06-02 08:02:21",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating downgraded from Hold to Sell as of 1 June 2026, reflecting a complex interplay of deteriorating technical indicators, modest financial performance, and valuation concerns. Despite some positive long-term growth metrics, the company’s overall quality and market positioning have raised caution among analysts, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4029123",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_technicaldot_4029123.png",
        "date": "2026-06-02 08:01:13",
        "description": "Kilitch Drugs (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a marginal day change of -0.03%, the stock’s technical parameters reveal a transition from a sideways trend to a mildly bearish stance, prompting a downgrade in its Mojo Grade from Hold to Sell as of 1 June 2026."
      },
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-hold-by-marketsmojo-4025970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KilitchDrugsInd_mojoScore_4025970.png",
        "date": "2026-06-01 10:10:51",
        "description": "Kilitch Drugs (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 01 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kilitch Drugs Surges 19.54%: Valuation and Technical Shifts Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-surges-1954-valuation-and-technical-shifts-drive-momentum-4009506",
        "imagepath": "",
        "date": "2026-05-24 15:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Stock jumps 10.88% on valuation upgrade</p>\n                    <p><strong>19 May:</strong> Valuation shifts to attractive amid market volatility</p>\n                    <p><strong>21 May:</strong> Upgraded to Hold as financial and technical trends improve</p>\n                    <p><strong>21 May:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>22 May:</strong> Week closes at ₹182.90, up 0.05% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹153.00</div></div>\n                    <..."
      },
      {
        "title": "Kilitch Drugs Upgraded to Hold as Financial and Technical Trends Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-upgraded-to-hold-as-financial-and-technical-trends-improve-4002096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_mojoScore_4002096.png",
        "date": "2026-05-21 08:01:16",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement across financial performance, valuation metrics, and technical indicators. The company’s recent quarterly results and evolving market trends have contributed to a more balanced outlook, signalling cautious optimism for investors in this pharmaceuticals micro-cap."
      }
    ],
    "total": 327,
    "sid": "189669",
    "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "27-May-2026",
      "details": "We are hereby submitting annual secretarial compliance report for the year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-May-2026",
      "details": "We are submitting hereby copy of newspaper publication of the extract of financial results for the quarter ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Audited Standalone And Consolidated Financial Results For The Quarter Ended 31St March 2026",
      "datetime": "15-May-2026",
      "details": "We are hereby submitting audited standalone and consolidated financial results for the quarter ended 31st March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26",
          "dt": "2026-03-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Kilitch Drugs Upgraded to Hold as Technicals Improve Amid Mixed Financial Signals

2026-06-09 08:02:09

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent price volatility and a challenging one-year return, the company’s underlying fundamentals and technical signals have prompted a reassessment of its market stance.

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-08 08:00:20

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite mixed signals from key technical indicators such as MACD, RSI, and moving averages, the stock’s recent price action and broader market context suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Kilitch Drugs (India) Ltd Faces Mixed Technical Signals Amid Price Momentum Shift

2026-06-04 08:00:37

Kilitch Drugs (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, monthly signals suggest caution, reflected in the company’s downgrade from Hold to Sell by MarketsMOJO on 1 June 2026.

Read full news article

Kilitch Drugs (India) Ltd: Technical Momentum Shifts Amid Mixed Signals

2026-06-03 08:00:29

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bearish trend to a sideways pattern. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock exhibits a complex interplay of technical indicators, reflecting both bullish and bearish signals across different timeframes.

Read full news article

Kilitch Drugs Downgraded to Sell Amid Mixed Financials and Bearish Technicals

2026-06-02 08:02:21

Kilitch Drugs (India) Ltd has seen its investment rating downgraded from Hold to Sell as of 1 June 2026, reflecting a complex interplay of deteriorating technical indicators, modest financial performance, and valuation concerns. Despite some positive long-term growth metrics, the company’s overall quality and market positioning have raised caution among analysts, prompting a reassessment of its investment appeal.

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-02 08:01:13

Kilitch Drugs (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a marginal day change of -0.03%, the stock’s technical parameters reveal a transition from a sideways trend to a mildly bearish stance, prompting a downgrade in its Mojo Grade from Hold to Sell as of 1 June 2026.

Read full news article

Kilitch Drugs (India) Ltd is Rated Hold by MarketsMOJO

2026-06-01 10:10:51

Kilitch Drugs (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 01 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Kilitch Drugs Surges 19.54%: Valuation and Technical Shifts Drive Momentum

2026-05-24 15:00:04

Key Events This Week

18 May: Stock jumps 10.88% on valuation upgrade

19 May: Valuation shifts to attractive amid market volatility

21 May: Upgraded to Hold as financial and technical trends improve

21 May: Technical momentum shifts amid mixed market signals

22 May: Week closes at ₹182.90, up 0.05% on the day

Week Open

₹153.00

<...

Read full news article

Kilitch Drugs Upgraded to Hold as Financial and Technical Trends Improve

2026-05-21 08:01:16

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement across financial performance, valuation metrics, and technical indicators. The company’s recent quarterly results and evolving market trends have contributed to a more balanced outlook, signalling cautious optimism for investors in this pharmaceuticals micro-cap.

Read full news article

View All News